摘要 背景及目的:壳聚糖支架复合成骨诱导后的骨髓间充质干细胞已经被证实是修复骨缺损的良好替代材料。然而,其成骨的具体过程以及支架的降解却研究较少。本研究的目的是通过观察壳聚糖支架复合成骨诱导后的骨髓间充质干细胞后的异位成骨过程来证实该复合材料的成骨能力,并探索支架降解与骨形成之间的关系。 方法:壳聚糖支架复合成骨诱导后的骨髓间充质干细胞(壳聚糖复合细胞组)和单纯壳聚糖支架(壳聚糖组)被分别植入SD大鼠的股骨肌袋内。 于术后2、4、6、8、12周,分别对大鼠股骨行CT扫描,并测定、统计分析两组的植入物CT值。随后取出标本,行HE染色和Masson染色,并测定、统计分析骨面积分数、支架面积分数以及胶原面积分数。 结果:影响学结果显示两组植入物的密度随时间延长而逐渐增高,但是在同一时间点,壳聚糖复合细胞组植入物的CT值明显高于壳聚糖组(P<0.05)。组织学检测结果显示从术后2周开始,两组均可观察到支架孔隙内的新骨和胶原蛋的形成并且随着时间延长而逐渐增加,以及支架随着骨形成的过程而逐渐降解。然而,统计分析结果显示,在同一时间点,壳聚糖复合细胞组的新生骨量以及胶原蛋白表达量明显高于壳聚糖组,而剩余支架要明显少于壳聚糖组。 结论:壳聚糖支架复合成骨诱导后的骨髓间充质干细胞是一种优秀的组织工程骨替代物,支架的降解与异位成骨过程一致。
Abstract Background Chitosan (CS) scaffolds combined with osteogenically induced bone marrow mesenchymal stem cells (BMSCs) have been proved to be promising substitutes for repairing bone defects. Nevertheless, the bone forming and scaffold biodegrading process are seldom studied. This study aimed to determine the osteogenic ability of chitosan/osteo-induced BMSCs composites via observing the bone forming process and explore the relationship between the bone formation and the scaffold biodegradation. Methods The CS/osteo-induced BMSCs composites (CS cells group) and the CS scaffolds (CS group) were respectively implanted into SD rat thigh muscles. At 2, 4, 6, 8, 12 weeks postoperatively, the rat femurs were scanned by CT, and the CT values of the implants were measured and comparatively analyzed. Subsequently the implants were harvested and underwent HE staining and Masson staining, and the percentages of bone area, scaffold area and collagen area were calculated and compared between two groups. Results The imaging results showed that the densities of implants of two groups gradually increased along with time, but the CT values of implants in the CS cells group were much higher than those in CS group at the same time point (P<0.05). The histological results showed that the de novo bone and collagen formed in the pores of the scaffolds and gradually increased since 2 weeks postoperatively in both two groups, and the scaffold gradually degraded along with the bone forming process. However, the comparative analysis results showed that the CS cells group gained more de novo bone and collagen formation, and remained less scaffold than the CS group at the same time point (P<0.05). Conclusions The CS/osteo-induced BMSCs composites are excellent bone tissue engineering substitutes, and the scaffold biodegradation is accordant with the bone formation.